Extensive Retinal Neovascularization as a Late Finding in Human Immunodeficiency Virus-Infected Patients with Immune Recovery Uveitis

Wright, Mary E.; Suzman, Daniel L.; Csaky, Karl G.; Masur, Henry; Polis, Michael A.; Robinson, Michael R.
April 2003
Clinical Infectious Diseases;4/15/2003, Vol. 36 Issue 8, p1063
Academic Journal
Reports on the observation of sixteen HIV-infected patients with inactive cytomegalovirus (CMV) retinitis who had discontinued systemic anti-CMV therapy while receiving highly active antiretroviral therapy. Number of patients who developed immune recovery uveitis; Characterization of CMV retinitis.


Related Articles

  • Uganda to double use of antiretrovirals in people with HIV. Wasswa, Henry // BMJ: British Medical Journal (International Edition);9/13/2008, Vol. 337 Issue 7670, p596 

    The article reports on Uganda's plans to introduce a program to increase the number of people infected with the HIV virus who are treated with antiretroviral drugs, and to set a new CD4 count of 350 cells at which patients will be given the antiretroviral treatments. A discussion of the...

  • Sarcoidosis in HIV-Infected Patients in the Era of Highly Active Antiretroviral Therapy. Foulon, Guillaume; Wislez, Marie; Naccache, Jean-Marc; Blanc, François-Xavier; Rabbat, Antoine; Israël-Biet, Dominique; Valeyre, Dominique; Mayaud, Charles; Candranel, Jacques // Clinical Infectious Diseases;2/1/2004, Vol. 38 Issue 3, p418 

    To analyze the impact of highly active antiretroviral therapy (HAART) on the characteristics and outcome of sarcoidosis in patients infected with human immunodeficiency virus (HIV), we identified HIV-infected patients in whom sarcoidosis was diagnosed between 1996 and 2000 from the admission...

  • Antiretroviral therapy at a district hospital in Ethiopia prevents death and tuberculosis in a cohort of HIV patients. Jerene, Degu; Næss, Are; Lindtjørn, Bernt // AIDS Research & Therapy;2006, Vol. 3, p10 

    Background: Although highly active antiretroviral therapy (HAART) reduces mortality in the developed world, it remains undocumented in resource-poor settings. We assessed the effect of HAART on patient mortality and tuberculosis incidence rate under routine clinical care conditions in Ethiopia....

  • Effect of a 14-Day Course of Foscarnet on Cytomegalovirus (CMV) Blood Markers in a Randomized Study of Human Immunodeficiency Virus-Infected Patients with Persistent CMV Viremia. Salmon-C é ron, Dominique; Fillet, Anne-Marie; Aboulker, Jean-Pierre; G é rard, Laurence; Houhou, Nadira; Carri è re, Isabelle; Ostinelli, Juliette; Vild é, Jean-Louis; Brun-V é zinet, Françoise; Leport, Catherine // Clinical Infectious Diseases;4/1/1999, Vol. 28 Issue 4, p901 

    Focuses on a study which compared the virological and clinical effects on cytomegalovirus infection of a course of intravenous foscarnet or no treatment in HIV-infected patients. Patients and methods; Results; Discussion.

  • Balancing the need to rapidly scale-up and improve clinical outcomes in antiretroviral programmes in developing countries: lessons from an Indian programmatic cohort study. Bock, Peter; Beyers, Nulda; Fidler, Sarah // Transactions of the Royal Society of Tropical Medicine & Hygiene;Oct2014, Vol. 108 Issue 10, p599 

    Antiretroviral treatment (ART) is highly effective reducing mortality and AIDS-related morbidity in HIV-infected people and at preventing transmission of HIV between individuals. The article reviewed for this commentary reported on data from an Indian ART cohort that showed low median baseline...

  • Activity of the Combination of Nelfinavir and Saquinavir Against Human Immunodeficiency Virus After Failure of Prior Protease Inhibitor Therapy. Kravcik, Stephen; Victor, Gary; Angel, Jonathan B.; Badley, Andrew D.; Cameron, D. William // Clinical Infectious Diseases;9/1/1999, Vol. 29 Issue 3, p702 

    Reports on the effectiveness of combining nelfinavir and saquinavir for the treatment of HIV infections. Details of a retrospective study on HIV-positive patients prescribed with nelfinavir and saquinavir; Effects of the drugs on the viral levels of the patients; Importance of treatment changes...

  • New Drug to Treat HIV/AIDS Approved. Nightingale, Stuart L. // JAMA: Journal of the American Medical Association;11/4/98, Vol. 280 Issue 17, p1472 

    Reports that the United States Food and Drug Administration (FDA) has approved efavirenz for use in combination with other antiretroviral agents in the treatment of HIV-1 infection. Background on resistant virus; Details on trials that were conducted; Side effects.

  • Renal Function in Chinese HIV-Positive Individuals following Initiation of Antiretroviral Therapy. Zhao, Yan; Zhang, Mingjie; Shi, Cynthia X.; Zhang, Yao; Cai, Weiping; Zhao, Qingxia; Li, Yong; Li, Huiqin; Liu, Xia; Chen, Limeng; Ma, Ye; Zhang, Fujie; Liu, Zhongfu; Wu, Zunyou // PLoS ONE;8/28/2015, Vol. 10 Issue 8, p1 

    Aim: To identify the prevalence and predictors of abnormal renal function among HIV-positive Chinese patients prior to antiretroviral therapy (ART) initiation and to evaluate subsequent changes in renal function after ART exposure. Methods: We conducted a nationwide cohort study of subjects...

  • Closing the Gap: Increases in Life Expectancy among Treated HIV-Positive Individuals in the United States and Canada. Samji, Hasina; Cescon, Angela; Hogg, Robert S.; Modur, Sharada P.; Althoff, Keri N.; Buchacz, Kate; Burchell, Ann N.; Cohen, Mardge; Gebo, Kelly A.; Gill, M. John; Justice, Amy; Kirk, Gregory; Klein, Marina B.; Korthuis, P. Todd; Martin, Jeff; Napravnik, Sonia; Rourke, Sean B.; Sterling, Timothy R.; Silverberg, Michael J.; Deeks, Stephen // PLoS ONE;Dec2013, Vol. 8 Issue 12, p1 

    Background: Combination antiretroviral therapy (ART) has significantly increased survival among HIV-positive adults in the United States (U.S.) and Canada, but gains in life expectancy for this region have not been well characterized. We aim to estimate temporal changes in life expectancy among...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics